Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Seifert

Showing results (51-60 of 145) with videos related to

Pageof 15
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 2, 2023
Molecular Imaging Biomarkers in Cardiooncology: A View on Established Technologies and Future PerspectivesDavid Kersting, Ilektra-Antonia Mavroeidi, Stephan Settelmeier, et al.
Oncology Research and Treatment|June 8, 2021
[18F]-Fluorodeoxyglucose Positron Emission Tomography/CT to Assess the Early Metabolic Response in Patients with Hormone Receptor-Positive HER2-Negative Metastasized Breast Cancer Treated with Cyclin-Dependent 4/6 Kinase InhibitorsRobert Seifert, Alina Küper, Mitra Tewes, et al.
American Journal of Clinical Pathology|July 22, 2024
Evaluating pathologist practices in peripheral blood smear review: A comprehensive practice surveyMargaret Moore, Xueyan Chen, Sam Sadigh, et al.
Theranostics|July 21, 2020
Analysis of PSMA expression and outcome in patients with advanced Prostate Cancer receiving <sup>177</sup>Lu-PSMA-617 Radioligand TherapyRobert Seifert, Konstantin Seitzer, Ken Herrmann, et al.
EJNMMI Physics|April 16, 2025
External phantom-based validation of a deep-learning network trained for upscaling of digital low count PET dataAnja Braune, René Hosch, David Kersting, et al.
Theranostics|July 21, 2020
Molecular analysis of circulating tumor cells of metastatic castration-resistant Prostate Cancer Patients receiving <sup>177</sup>Lu-PSMA-617 Radioligand TherapyKatharina Kessel, Robert Seifert, Matthias Weckesser, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 20, 2024
Influence of dosimetry accuracy on the correlation with treatment outcome in a preliminary PSMA radiopharmaceutical therapy studyJiaxi Hu, Robert Seifert, Sofia Karkampouna, et al.
Annals of Nuclear Medicine|December 2, 2021
Prostate-specific membrane antigen and fibroblast activation protein distribution in prostate cancer: preliminary data on immunohistochemistry and PET imagingKatharina Kessel, Robert Seifert, Matthias Weckesser, et al.
Cancers|August 7, 2021
Evaluation of <sup>68</sup>Ga-PSMA-11 PET-MRI in Patients with Advanced Prostate Cancer Receiving <sup>177</sup>Lu-PSMA-617 Therapy: A Radiomics AnalysisWolfgang Roll, Philipp Schindler, Max Masthoff, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 27, 2021
Repeatability of <sup>68</sup>Ga-PSMA-HBED-CC PET/CT-Derived Total Molecular Tumor VolumeRobert Seifert, Patrick Sandach, David Kersting, et al.
Pageof 15

Showing results (51-60 of 145) with videos related to

Sort By:
Pageof 15
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 2, 2023
Molecular Imaging Biomarkers in Cardiooncology: A View on Established Technologies and Future PerspectivesDavid Kersting, Ilektra-Antonia Mavroeidi, Stephan Settelmeier, et al.
Oncology Research and Treatment|June 8, 2021
[18F]-Fluorodeoxyglucose Positron Emission Tomography/CT to Assess the Early Metabolic Response in Patients with Hormone Receptor-Positive HER2-Negative Metastasized Breast Cancer Treated with Cyclin-Dependent 4/6 Kinase InhibitorsRobert Seifert, Alina Küper, Mitra Tewes, et al.
American Journal of Clinical Pathology|July 22, 2024
Evaluating pathologist practices in peripheral blood smear review: A comprehensive practice surveyMargaret Moore, Xueyan Chen, Sam Sadigh, et al.
Theranostics|July 21, 2020
Analysis of PSMA expression and outcome in patients with advanced Prostate Cancer receiving <sup>177</sup>Lu-PSMA-617 Radioligand TherapyRobert Seifert, Konstantin Seitzer, Ken Herrmann, et al.
EJNMMI Physics|April 16, 2025
External phantom-based validation of a deep-learning network trained for upscaling of digital low count PET dataAnja Braune, René Hosch, David Kersting, et al.
Theranostics|July 21, 2020
Molecular analysis of circulating tumor cells of metastatic castration-resistant Prostate Cancer Patients receiving <sup>177</sup>Lu-PSMA-617 Radioligand TherapyKatharina Kessel, Robert Seifert, Matthias Weckesser, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 20, 2024
Influence of dosimetry accuracy on the correlation with treatment outcome in a preliminary PSMA radiopharmaceutical therapy studyJiaxi Hu, Robert Seifert, Sofia Karkampouna, et al.
Annals of Nuclear Medicine|December 2, 2021
Prostate-specific membrane antigen and fibroblast activation protein distribution in prostate cancer: preliminary data on immunohistochemistry and PET imagingKatharina Kessel, Robert Seifert, Matthias Weckesser, et al.
Cancers|August 7, 2021
Evaluation of <sup>68</sup>Ga-PSMA-11 PET-MRI in Patients with Advanced Prostate Cancer Receiving <sup>177</sup>Lu-PSMA-617 Therapy: A Radiomics AnalysisWolfgang Roll, Philipp Schindler, Max Masthoff, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 27, 2021
Repeatability of <sup>68</sup>Ga-PSMA-HBED-CC PET/CT-Derived Total Molecular Tumor VolumeRobert Seifert, Patrick Sandach, David Kersting, et al.
Pageof 15